echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > National Medical Insurance Administration: 271 drugs passed the preliminary formal review of the new version of the medical insurance catalog

    National Medical Insurance Administration: 271 drugs passed the preliminary formal review of the new version of the medical insurance catalog

    • Last Update: 2021-08-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Medical Network, August 2 News On the evening of July 30, the official website of the National Medical Insurance Administration issued an announcement on the announcement that the adjustment of the National Medical Insurance Drug Catalogue for 2021 passed the preliminary form of review of drugs and information
    .
    271 drugs passed the preliminary formal review
    .

     
    The document shows that from 9:00 on July 1, 2021 to 17:00 on July 14, 2021, the National Medical Insurance Bureau received a total of 501 pieces of enterprise declaration information, involving 474 drugs
    .
    After review, 271 drugs passed the preliminary formal review
    .
    Among the non-catalog drugs that passed the preliminary formal review, the newly marketed drugs after 2016 accounted for 93.
    02%
    .
     
    The National Medical Insurance Bureau stated that the drugs and related information that have passed the preliminary formal review will be publicized in accordance with the procedures, and the publicity time will be July 30-August 5, 2021
    .
    The specific list is as follows:
     
    Medical Network, August 2 News On the evening of July 30, the official website of the National Medical Insurance Administration issued an announcement on the announcement that the adjustment of the National Medical Insurance Drug Catalogue for 2021 passed the preliminary form of review of drugs and information
    .
    271 drugs passed the preliminary formal review
    .

     
    The document shows that from 9:00 on July 1, 2021 to 17:00 on July 14, 2021, the National Medical Insurance Bureau received a total of 501 pieces of enterprise declaration information, involving 474 drugs
    .
    After review, 271 drugs passed the preliminary formal review
    .
    Among the non-catalog drugs that passed the preliminary formal review, the newly marketed drugs after 2016 accounted for 93.
    02%
    .
     
      The National Medical Insurance Bureau stated that the drugs and related information that have passed the preliminary formal review will be publicized in accordance with the procedures, and the publicity time will be July 30-August 5, 2021
    .
    The specific list is as follows:
     
      Medical Network, August 2 News On the evening of July 30, the official website of the National Medical Insurance Administration issued an announcement on the announcement that the adjustment of the National Medical Insurance Drug Catalogue for 2021 passed the preliminary form of review of drugs and information
    .
    271 drugs passed the preliminary formal review
    .

     
      The document shows that from 9:00 on July 1, 2021 to 17:00 on July 14, 2021, the National Medical Insurance Bureau received a total of 501 pieces of enterprise declaration information, involving 474 drugs
    .
    After review, 271 drugs passed the preliminary formal review
    .
    Among the non-catalog drugs that passed the preliminary formal review, the newly marketed drugs after 2016 accounted for 93.
    02%
    .
    Enterprise enterprise enterprise medicine medicine medicine
     
      The National Medical Insurance Bureau stated that the drugs and related information that have passed the preliminary formal review will be publicized in accordance with the procedures, and the publicity time will be July 30-August 5, 2021
    .
    The specific list is as follows:
     
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.